Market Signal Briefing

Key Takeaways Novo Nordisk agreed with the U.S. Administration to lower Ozempic and Wegovy prices from 2026.The deal aims to broaden access through Medicare Part D, Medicaid, and direct-to-patient channels.Novo Nordisk expects a low single-digit sales hit in 2026 as it faces margin and competitive pressures.
Novo Nordisk (NVO - Free Report) is a dominant player in the cardiometabolic space, which markets its blockbuster semaglutide-based (GLP-1) drugs — Ozempic (for type II diabetes [T2D]) and Wegovy (for obesity).

Following President Trump’s comments last month on forthcoming government action to reduce the prices of Ozempic and Wegovy, Novo Nordisk disclosed last week that it has reached an agreement with the U.S. Administration to implement price reductions beginning in 2026. The agreement is designed to broaden access and improve affordability for semaglutide therapies, including Wegovy and Ozempic, across Medicare Part D, Medicaid, and the direct-to-patient cash channel.

These drugs, which currently cost over $1,000 per month, will be priced at $350 through TrumpRx, a federal government website, slated to launch in early 2026, with future oral versions offered at $150 if approved. The Medicare Part D coverage for anti-obesity medicines will be introduced through a new pilot program expected to reach most Part D beneficiaries, while Novo Nordisk will benefit from a three-year tariff exemption. Trump’s negotiated cuts will allow Medicare and Medicaid to pay $245 for Ozempic and Wegovy, enabling coverage of Wegovy and Zepbound, with Medicare patients paying a $50 monthly co-pay.

NVO emphasized that these measures will expand access through improved affordability for semaglutide therapies, particularly authentic Wegovy, within Medicare. Novo Nordisk anticipates a direct, low single-digit negative impact on global sales growth in 2026 as implementation begins, with full financial guidance for 2026 to be provided alongside full-year 2025 results, to be announced on Feb. 4, 2026. The company and the U.S. Administration will now work to finalize the agreement’s operational details.

However, there’s still room for concern. Lower prices for Ozempic and Wegovy also introduce meaningful uncertainty around the long-term economics of GLP-1 development. A mandated pricing reset in the United States, NVO’s most important obesity market, compresses the profitability of its two largest revenue contributors at a time when the company is already contending with slowing demand trends, rising competitive pressure from Eli Lilly (LLY - Free Report) , and persistent headwinds from compounded semaglutide alternatives. Against this backdrop, the incremental volumes generated through expanded Medicare coverage may not fully offset the margin erosion expected once price reductions take effect.

These pressures also raise broader concerns about Novo Nordisk’s competitive positioning and its ability to sustain innovation within its core franchises. Following its July 2025 guidance cut and the September restructuring program targeting 9,000 job reductions, the company has already signaled a need to rebalance costs, streamline operations, and refocus capital allocation. A sharp decline in GLP-1 pricing could further strain financial flexibility and, over time, dampen incentives for continued R&D investment in next-generation therapeutics. While the new agreement may expand patient reach, it simultaneously heightens execution risk and adds another layer of uncertainty to NVO’s medium-term growth trajectory.

NVO’s Peers in the Obesity SpaceEli Lilly is Novo Nordisk’s fierce competitor in the diabetes/obesity space, which markets its tirzepatide-based drugs, Mounjaro (T2D) and Zepbound (obesity). Despite being on the market for less than three years, Mounjaro and Zepbound have become LLY’s key top-line drivers. In the first nine months of 2025, the drugs generated combined sales of $24.8 billion, accounting for 54% of Eli Lilly’s total revenues. LLY’s Mounjaro and Zepbound follow a dual mechanism of action as a GIP and GLP-1 RA.

Several other companies, like Viking Therapeutics (VKTX - Free Report) , are also making rapid progress in the development of GLP-1-based candidates in their clinical pipeline. Viking Therapeutics’ dual GIPR/GLP-1 RA, VK2735, is being developed both as oral and subcutaneous formulations for the treatment of obesity. In August 2025, VKTX announced mixed top-line results from a mid-stage study evaluating the safety and efficacy of the oral formulation of VK2735, which caused the stock to drop significantly. Viking Therapeutics plans to meet with the FDA before this year’s end to discuss the next steps for oral VK2735. Phase III obesity studies with the subcutaneous formulation of VK2735 are currently underway.

NVO Stock’s Price, Valuation & EstimatesYear to date, Novo Nordisk shares have lost 46.9% against the industry’s 6.4% growth. The company has also underperformed the sector and the S&P 500 during the same time frame, as seen in the chart below.

NVO Stock Underperforms the Industry, Sector & the S&P 500Image Source: Zacks Investment Research

Novo Nordisk is trading at a discount to the industry, as seen in the chart below. Going by the price/earnings ratio, the company’s shares currently trade at 11.80 forward earnings, which is lower than 15.57 for the industry. The stock is trading much below its five-year mean of 29.25.

NVO Stock ValuationImage Source: Zacks Investment Research

Earnings estimates for 2025 have deteriorated from $3.85 to $3.67 per share over the past 60 days. During the same time frame, Novo Nordisk’s 2026 earnings per share estimates have declined from $3.96 to $3.91.

NVO Estimate MovementImage Source: Zacks Investment Research

Novo Nordisk currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

American Vanguard Corporation (AVD) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST

Company Participants

Anthony Young - Director of Investor Relations
Douglas Kaye - Chairman & CEO
David Johnson - Chief Financial Officer

Conference Call Participants

Michael Harrison - Seaport Research Partners
Wayne Pinsent - The Gabelli Healthcare & Wellness Trust
Charles Rose
Dmitry Silversteyn - Water Tower Research LLC

Presentation

Operator

Greetings, and welcome to the American Vanguard Third Quarter 2025 Earnings Conference Call. [Operator Instructions] And please note, this conference is being recorded.

I will now turn the conference over to your host, Mr. Anthony Young, Director of Investor Relations. Sir, the floor is yours.

Anthony Young
Director of Investor Relations

Thank you, operator. Good morning, and welcome to American Vanguard's Third Quarter 2025 Earnings Review. Our prepared remarks will be led by Dak Kaye, Chief Executive Officer; and David Johnson, Chief Financial Officer. A copy of today's release, along with supplemental slides, are available on our website. A replay of the webcast and transcript from this event will be available on our website shortly as well.

Before we begin our comments, we'd like to remind everyone that today's press release and certain of our comments on the call include non-GAAP figures and forward-looking statements, and actual results may differ materially. Please refer to the cautionary language included in our press release and slides and to the risk factors described in our SEC filings, all of which are available on our website.

It is now my pleasure to turn the call over to CEO, Dak Kaye.

Douglas Kaye
Chairman & CEO

Thank you, Anthony, and welcome, everyone, to our third quarter 2025 earnings conference call. When I joined the team 11 months ago, my directive was simplify, prioritize and deliver, and that is what we are doing. Our adjusted EBITDA increased from $1.8 million in the year ago period

Recommended For You

Nothing concentrates the mind like a suitor in the wings.

After ITV PLC (LSE:ITV) last week confirmed Comcast is in talks to buy the UK broadcaster's Media & Entertainment arm (the broadcast and streaming bit), UBS ran the numbers on what that could mean, while keeping a cool head and a 'sell' rating with a 12-month target of 72p, 7p lower than the current price.

Starting with the valuation, the figure touted for the M&E arm is £1.6 billion on an enterprise valuation basis. UBS’s discounted cash flow (DCF) is £1.5 billion, roughly in the same ballpark at eight times forecast 2026 operating profit.

If ITV banked this and used all of it to buy back shares, earnings per share (EPS) could be lifted to about 10p versus a 7.7p otherwise; more than 20% accretive.

On that arithmetic, the shares would trade on roughly seven times EPS, cheaper than listed peer Banijay at nine times.

There are plenty of caveats, though: There has not yet been a firm bid, and management has previously talked up the value of keeping production and distribution under one roof.

That's not to mention that any deal would face intense regulatory scrutiny, as the UK’s biggest commercial public broadcaster could end up owned by a non-UK group, with Comcast already owning Sky.

UBS also tweaked its model after ITV’s third-quarter update: revenue was better, mostly timing in Studios, but guidance for fourth-quarter TV total advertising revenue (TAR) was soft at minus 9% year on year.

One-off cost savings of £35 million are planned in 2025. Net effect: 2025 EPS nudged up 2%, 2026 cut 5% to 7.75p, assuming 2026 TAR grows 2% and no extra savings.

Howard Hughes Holdings (HHH - Free Report) reported $390.24 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 19.3%. EPS of $2.02 for the same period compares to $1.95 a year ago.

The reported revenue represents a surprise of +17.71% over the Zacks Consensus Estimate of $331.53 million. With the consensus EPS estimate being $1.56, the EPS surprise was +29.49%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Howard Hughes Holdings performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Master Planned Community land sales: $248.47 million compared to the $199.43 million average estimate based on two analysts. The reported number represents a change of +25.3% year over year.Revenues- Operating Assets Segment: $117.18 million versus $114.18 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change.Revenues- Master Planned Communities Segment: $271.58 million versus the two-analyst average estimate of $217.38 million. The reported number represents a year-over-year change of +27.7%.Segment EBT- Master Planned Communities: $205.01 million compared to the $153.59 million average estimate based on two analysts.View all Key Company Metrics for Howard Hughes Holdings here>>>

Shares of Howard Hughes Holdings have returned +2.3% over the past month versus the Zacks S&P 500 composite's +0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Let's take a look at what these Wall Street heavyweights have to say about Blue Bird (BLBD - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Blue Bird currently has an average brokerage recommendation (ABR) of 1.63, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by eight brokerage firms. An ABR of 1.63 approximates between Strong Buy and Buy.

Of the eight recommendations that derive the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 62.5% and 12.5% of all recommendations.

Brokerage Recommendation Trends for BLBD

Check price target & stock forecast for Blue Bird here>>>

While the ABR calls for buying Blue Bird, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is BLBD a Good Investment?Looking at the earnings estimate revisions for Blue Bird, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $4.04.

Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Blue Bird. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Blue Bird.

Petrobras (PBR - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, PBR broke through the 200-day moving average, which suggests a long-term bullish trend.

The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.

PBR could be on the verge of another rally after moving 10.9% higher over the last four weeks. Plus, the company is currently a Zacks Rank #3 (Hold) stock.

Looking at PBR's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 2 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well.

Investors may want to watch PBR for more gains in the near future given the company's key technical level and positive earnings estimate revisions.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about Dell Technologies (DELL - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Dell Technologies currently has an average brokerage recommendation (ABR) of 1.52, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 22 brokerage firms. An ABR of 1.52 approximates between Strong Buy and Buy.

Of the 22 recommendations that derive the current ABR, 15 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 68.2% and 9.1% of all recommendations.

Brokerage Recommendation Trends for DELL

Check price target & stock forecast for Dell Technologies here>>>

The ABR suggests buying Dell Technologies, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Should You Invest in DELL?Looking at the earnings estimate revisions for Dell Technologies, the Zacks Consensus Estimate for the current year has increased 0.1% over the past month to $9.54.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Dell Technologies. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Dell Technologies may serve as a useful guide for investors.

For the quarter ended September 2025, Telephone & Data Systems (TDS - Free Report) reported revenue of $308.52 million, down 74.8% over the same period last year. EPS came in at $0.07, compared to $0.01 in the year-ago quarter.

The reported revenue represents a surprise of -23.31% over the Zacks Consensus Estimate of $402.31 million. With the consensus EPS estimate being -$0.06, the EPS surprise was +216.67%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how TDS performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

TDS Telecom Residential connections - Broadband - Wireline, Incumbent: 225.5 thousand versus 228.87 thousand estimated by two analysts on average.TDS Telecom Residential connections - Broadband - Wireline, Expansion: 150.7 thousand versus the two-analyst average estimate of 154.62 thousand.TDS Telecom Residential connections - Broadband - Cable: 186.1 thousand versus the two-analyst average estimate of 186.41 thousand.TDS Telecom Residential connections - Broadband - Total: 562.4 thousand versus the two-analyst average estimate of 569.9 thousand.Operating Revenues- TDS Telecom- Service: $254.97 million versus $261.39 million estimated by three analysts on average.Operating Revenues- TDS Telecom: $255.11 million versus the three-analyst average estimate of $261.45 million.Operating Revenues- All other: $6.29 million versus $5.46 million estimated by three analysts on average.Operating Revenues- TDS Telecom- Service- Residential - Wireline, Expansion: $39.61 million versus the two-analyst average estimate of $36.96 million.Operating Revenues- TDS Telecom- Service- Residential - Cable: $60.23 million compared to the $62.29 million average estimate based on two analysts.Revenues from contracts with customers- Total- Service - Residential: $181.75 million versus $185.57 million estimated by two analysts on average.Revenues from contracts with customers- Total- Service - Commercial: $34.07 million compared to the $34.93 million average estimate based on two analysts.Revenues from contracts with customers- Total- Service - Wholesale: $38.37 million versus $42.34 million estimated by two analysts on average.View all Key Company Metrics for TDS here>>>

Shares of TDS have returned -1.6% over the past month versus the Zacks S&P 500 composite's +0.3% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tutor Perini (TPC - Free Report) .

Tutor Perini currently has an average brokerage recommendation (ABR) of 1.40, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by five brokerage firms. An ABR of 1.40 approximates between Strong Buy and Buy.

Of the five recommendations that derive the current ABR, four are Strong Buy, representing 80% of all recommendations.

Brokerage Recommendation Trends for TPC

Check price target & stock forecast for Tutor Perini here>>>

While the ABR calls for buying Tutor Perini, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is TPC Worth Investing In?In terms of earnings estimate revisions for Tutor Perini, the Zacks Consensus Estimate for the current year has increased 6.1% over the past month to $4.01.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Tutor Perini. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Tutor Perini may serve as a useful guide for investors.

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium service makes this easier. It features daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All of these can help you quickly identify what stocks to buy, what to sell, and what are today's hottest industries.

It also includes the Focus List, a long-term portfolio of top stocks that have all the elements to beat the market.

Breaking Down the Zacks Focus ListIf you could, wouldn't you jump at the chance for access to a curated list of stocks to kickstart your investing journey?

That's what the Zacks Focus List offers. It's a portfolio of 50 stocks that serve as a starting point for long-term investors to build their individual portfolios. The stocks included in the list are set to outperform the market over the next 12 months.

What makes the Focus List even more helpful is that each selection is accompanied by a full Zacks Analyst Report, which explains the reasoning behind every stock's selection and why we believe it's a good pick for the long-term.

The portfolio's past performance only solidifies why investors should consider it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500's return of 9.38%. Cumulatively, the portfolio has returned 2,519.23% while the S&P returned 854.95%. Returns are for the period of February 1, 1996 to March 31, 2021.

Focus List MethodologyWhen stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.

Brokerage analysts are in charge of determining a company's growth and profitability expectations, or earnings estimates. These analysts work together with company management to evaluate all factors that may affect future earnings, like interest rates, the economy, and sector and industry optimism.

What a company will earn down the road also needs to be taken into consideration, and this is why earnings estimate revisions are so important.

Stocks that receive upward earnings estimate revisions are more likely to receive even more upward changes in the future. For example, if an analyst raised their estimates last month, they're more likely to do it again this month, and other analysts are likely to do the same.

Harnessing the power of earnings estimate revisions is where the Zacks Rank comes in. The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions to make it easier to build a winning portfolio.

There are four main factors behind the Zacks Rank: Agreement, Magnitude, Upside, and Surprise. Each one of these features is then given a raw score that's recalculated every night and compiled into the Rank. Using this data, stocks are classified into five groups, ranging from "Strong Buy" to "Strong Sell."

The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts.

Since stock prices respond to revisions, it can be very profitable to buy stocks with rising earnings estimates. By buying Focus List stocks, then, you're likely getting into companies whose future earnings estimates will be raised, potentially leading to price momentum.

Focus List Spotlight: HCA Healthcare (HCA - Free Report) HCA Healthcare is the largest non-governmental operator of acute care hospitals in the United States. Headquartered in Nashville, TN, it operates hospitals and related health care entities. At the end of 2024, the company operated 190 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

Since being added to the Focus List on January 7, 2019 at $123.39 per share, shares of HCA have increased 286.26% to $476.61. The stock is currently a #1 (Strong Buy) on the Zacks Rank.

Eight analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $1.04 to $27.21. HCA also boasts an average earnings surprise of 12.4%.

Moreover, analysts are expecting HCA's earnings to grow 23.9% for the current fiscal year.

Reveal Winning StocksUnlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. You'll quickly identify which stocks to buy, hold and sell, and target today's hottest industries, to help improve the performance of your portfolio. Gain full access now >>

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about Celestica (CLS - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Celestica currently has an average brokerage recommendation (ABR) of 1.47, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 17 brokerage firms. An ABR of 1.47 approximates between Strong Buy and Buy.

Of the 17 recommendations that derive the current ABR, 12 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 70.6% and 11.8% of all recommendations.

Brokerage Recommendation Trends for CLS

Check price target & stock forecast for Celestica here>>>

While the ABR calls for buying Celestica, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Should You Invest in CLS?Looking at the earnings estimate revisions for Celestica, the Zacks Consensus Estimate for the current year has increased 7.9% over the past month to $5.9.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Celestica. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Celestica may serve as a useful guide for investors.

After reaching an important support level, Pebblebrook Hotel (PEB - Free Report) could be a good stock pick from a technical perspective. PEB surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.

One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down trend.

Over the past four weeks, PEB has gained 10.8%. The company is currently ranked a Zacks Rank #2 (Buy), another strong indication the stock could move even higher.

Looking at PEB's earnings estimate revisions, investors will be even more convinced of the bullish uptrend. There have been 5 higher compared to none lower for the current fiscal year, and the consensus estimate has moved up as well.

Investors should think about putting PEB on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.

Maplebear (CART - Free Report) reported $939 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 10.2%. EPS of $0.51 for the same period compares to $0.42 a year ago.

The reported revenue represents a surprise of +0.49% over the Zacks Consensus Estimate of $934.4 million. With the consensus EPS estimate being $0.50, the EPS surprise was +2%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Maplebear performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Gross Transaction Value (GTV): $9.17 billion compared to the $9.1 billion average estimate based on nine analysts.Orders: 83.4 million compared to the 82.7 million average estimate based on seven analysts.Revenue- Advertising and other: $269 million versus the nine-analyst average estimate of $271.88 million.Revenue- Transaction: $670 million versus the nine-analyst average estimate of $663.02 million.View all Key Company Metrics for Maplebear here>>>

Shares of Maplebear have returned -4.1% over the past month versus the Zacks S&P 500 composite's +0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Akamai Technologies (AKAM - Free Report) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AKAM broke through the 50-day moving average, which suggests a short-term bullish trend.

The 50-day simple moving average is one of three major moving averages used by traders and analysts to determine support or resistance levels for a wide range of securities. But the 50-day is considered to be more important because it's the first marker of an up or down trend.

AKAM could be on the verge of another rally after moving 14.3% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.

The bullish case solidifies once investors consider AKAM's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 2 higher, while the consensus estimate has increased too.

Investors should think about putting AKAM on their watchlist given the ultra-important technical indicator and positive move in earnings estimate revisions.

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium service makes this easier. It features daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter. All of these can help you quickly identify what stocks to buy, what to sell, and what are today's hottest industries.

It also includes the Focus List, a long-term portfolio of top stocks that have all the elements to beat the market.

Breaking Down the Zacks Focus ListBuilding an investment portfolio from scratch can be difficult, so if you could, wouldn't you take a peek at a curated list of top stocks?

That's what the Zacks Focus List, a portfolio of 50 stocks, offers investors. Not only does it serve as a starting point for long-term investors, but all stocks included in the list are poised to outperform the market over the next 12 months.

Additionally, each selection is accompanied by a full Zacks Analyst Report, something that makes the Focus List even more valuable. The report explains in detail why each stock was picked and why we believe it's good for the long-term.

The portfolio's past performance only solidifies why investors should consider it as a starting point. For 2020, the Focus List gained 13.85% on an annualized basis compared to the S&P 500's return of 9.38%. Cumulatively, the portfolio has returned 2,519.23% while the S&P returned 854.95%. Returns are for the period of February 1, 1996 to March 31, 2021.

Focus List MethodologyWhen stocks are picked for the Focus List, it reflects our enduring reliance on the power of earnings estimate revisions.

Earnings estimates, or expectations of growth and profitability, come from brokerage analysts who track publicly traded companies; these analysts work together with company management to analyze every aspect that may affect future earnings, like interest rates, the economy, and sector and industry optimism.

What a company will earn down the road also needs to be taken into consideration, and this is why earnings estimate revisions are so important.

When a stock receives upward earnings estimate revisions, it will likely get even more positive changes in the future. For instance, if an analyst raised their earnings outlook last month, they'll probably do so again this month, and other analysts will follow.

Harnessing the power of earnings estimate revisions is where the Zacks Rank comes in. The Zacks Rank is a unique, proprietary stock-rating model that utilizes changes to a company's quarterly earnings expectations to help investors build a winning portfolio.

Four primary factors make up the Zacks Rank: Agreement, Magnitude, Upside, and Surprise. Each is given a raw score that's recalculated every night and compiled into the Rank, and with this data, stocks are then classified into five groups, ranging from "Strong Buy" to "Strong Sell."

The Focus List is comprised of stocks hand-picked from a long list of #1 (Strong Buy) or #2 (Buy) ranked companies, meaning that each new addition boasts a bullish earnings consensus among analysts.

It can be very profitable to buy stocks with rising earnings estimates, as stock prices respond to revisions. By adding Focus List stocks, there's a great chance you'll be getting into companies whose future earnings estimates will be raised, which can lead to price momentum.

Focus List Spotlight: American Express (AXP - Free Report) Founded in 1850, NY-based American Express Company is a diversified financial services company, offering charge and credit payment card products, and travel-related services worldwide. AmEx earns revenue through both transaction fees and interest income, supported by a closed-loop payment network. Unlike open-loop peers (e.g., Visa or Mastercard), its integrated system allows AmEx to engage directly with both merchants and cardholders. This setup enables deeper customer insights, targeted marketing, and strong customer loyalty.

AXP, a #3 (Hold) stock, was added to the Focus List on December 23, 2021 at $162.47 per share. Since then, shares have increased 126.84% to $368.54.

Eight analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, while the Zacks Consensus Estimate has increased $0.07 to $15.35. AXP also boasts an average earnings surprise of 4%.

Moreover, analysts are expecting AXP's earnings to grow 15% for the current fiscal year.

Reveal Winning StocksUnlock all of our powerful research, tools and analysis, including the Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. You'll quickly identify which stocks to buy, hold and sell, and target today's hottest industries, to help improve the performance of your portfolio. Gain full access now >>

The $5M $FUNToken giveaway, live at 5m.fun, continues to reshape the $FUN ecosystem by combining two of the most powerful forces in crypto: community engagement and token scarcity. Through a transparent staking mechanism, the campaign rewards participation while simultaneously removing tokens from active circulation. This is a combination that drives both loyalty and scarcity in equal measure.

At its core, this initiative turns engagement into economic impact. Every staker becomes part of a growing global community that fuels the $FUN economy while tightening its supply dynamics.

Engagement as a Growth EngineThe $FUNToken community has long been a defining strength for the project, and the ongoing giveaway amplifies this connection. Participants are active contributors, staking their tokens, sharing updates, and tracking milestones on the 5m.fun dashboard.

Across social channels like the FUNToken Telegram group, discussions about rewards, staking milestones, and leaderboard positions have created a renewed sense of shared momentum. The campaign’s transparency - with every staked token visible on-chain - transforms engagement into proof of participation.

Adding to this dynamic is the FUN Message Scoring Bot, which rewards user activity and discussion quality. Together, these tools turn social interaction into measurable community strength, reinforcing $FUN’s position as a holder-driven ecosystem.

The Mechanics of Reduced CirculationWhat sets this giveaway apart is how participation directly influences token supply. When users stake $FUN, their tokens are temporarily removed from circulation. This move ends up effectively reducing the number available for trading.

Over 8.7 million $FUN have already been staked, representing a significant contraction in active supply. This means that every new staker not only joins the community but also contributes to tightening liquidity.

Unlike typical giveaways that release new tokens into the market, this campaign creates a supply-side adjustment. This is a strategic form of scarcity driven by user action, not artificial limitation. The more users engage, the less freely circulating supply remains, reinforcing a self-sustaining cycle of demand and value retention.

A Transparent, Fair, and Trust-Based SystemThe foundation of this community-driven supply shock is a verified Ethereum smart contract that manages all staking, milestones, and reward distributions automatically.

● Fair Distribution: Rewards are allocated proportionally based on the staked amount and the timing of participation.

● Instant Access: Participants can withdraw unlocked rewards immediately once price milestones are met.

● Full Transparency: All staking data, global totals, and milestones are visible to anyone via 5m.fun, ensuring total trust in the system.

This architecture removes human bias and central control, empowering the community to see, in real time, how engagement and commitment directly shape the ecosystem.

From Participation to Price ResilienceAccording to CoinMarketCap, $FUNToken ($FUN) is currently trading near $0.00256 USD, with a market capitalization of $27.66 million, 24-hour trading volume of $16.32 million, and a total holder base of approximately 98,780 wallets.

While prices may experience short-term movement, the deeper trend lies in behavioral change. With tokens being locked through staking, active circulation is shrinking - creating conditions for potential value consolidation over time.

Community enthusiasm, combined with transparent staking and milestone-based rewards, is generating a psychological anchor around holding rather than selling. It’s a subtle but powerful shift: users are no longer simply reacting to price, they’re participating in shaping it.

Why This Synergy MattersIn most token economies, community engagement and token scarcity operate independently. FUNToken’s giveaway fuses them into one mechanism.

● Engagement drives staking.

● Staking reduces circulation.

● Reduced circulation strengthens long-term market confidence.

Every staked token becomes both a signal of trust and a mechanism of scarcity. As participation grows, so does the project’s resilience — not through speculation, but through the shared commitment of thousands of active contributors.

ConclusionThe $5M $FUNToken giveaway has become a masterclass in aligning incentives between users and the market. By encouraging community engagement while naturally reducing token circulation, FUNToken has created a structure where growth and scarcity work hand in hand.

The more users stake and participate, the stronger the token’s foundation becomes — turning everyday community actions into forces that shape market stability and long-term value.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Regulation

Jury Struggles With Complexity of MEV Bros Case, Leading to Mistrial

TL;DR A US federal jury was unable to reach a verdict in the case involving brothers Anton and James Peraire-Bueno, accused of extracting $25 million

flash news

Fee-Sharing Buzz Sends UNI to Multi-Month Highs, Boosting Market Confidence

The UNI token has rebounded to $6.86, driven by renewed interest in the “fee switch,” a proposal that would allow revenue sharing with holders.

CryptoNews

Japan’s Proposed Custody Rule Highlights Push for Stronger Oversight

TL;DR: Japan’s FSA proposes a rule to separate customer and company assets on crypto platforms. Custodians must disclose storage practices and hold fiat in trust

flash news

Bank of England’s Stablecoin Consultation Sets Stage for Digital Payments by 2026

The Bank of England has released a draft regulatory framework that would limit individual stablecoin holdings and introduce new rules for backing and oversight.

flash news

Caroline Pham’s CFTC Initiative Puts Leveraged Crypto Trading on Policy Agenda

Acting CFTC Commissioner Caroline Pham stated this week on X that she is actively advancing a framework to enable leveraged spot crypto trading in the

Markets

Trump’s $2,000 Tariff Dividend and Its Potential Effect on Crypto Markets

TL;DR: President Donald Trump announced a “tariff dividend” of at least $2,000 for eligible citizens, funded by tariffs. Crypto analysts predict a market surge, comparing

The cryptocurrency market rallied on Monday following the Senate vote to end the United States government shutdown. The Senate has approved the deal to reopen government operations, a move that stirred confidence across the global financial landscape. Digital tokens recorded remarkable uptrends, with Bitcoin reclaiming $106,000 after gaining roughly 5%.

This November, the Starknet price prediction 2025 has suddenly intensified after STRK surged over 100% this week and by 350% in the past 30 days. While the Starknet price continues to show a short-term rally, this renewed momentum came following the mainnet “Stwo” upgrade in the past week; the long-term outlook remains tied to whether short-term strength can evolve into a sustained recovery from its deep drawdown.

Mainnet Upgrades Ignite a Short-Term ReboundThe STRK/USD rally gained traction after Starknet confirmed that its Stwo prover update went live on the mainnet on November 5, quickly becoming the catalyst for this week’s surge. This momentum built on a broader 30-day recovery that took the token from $0.039 to $0.186, marking a 350% rise and one of STRK’s strongest short-term climbs since many months.

However, despite the recent enthusiasm, STRK price USD still trades more than 90% below its 2024 ATH of $2.78. Investors view the rally as encouraging but not yet transformative, especially considering that the token remains one of the biggest underperformers from its category over the long term.

Even after the “Stwo” update, it only managed to remain second in netflows, below Arbitrum, with $175 million in positive net flows last week. The broader market still questions whether STRK’s rebound is the beginning of a structural recovery or another short-lived reaction.

Fundamental Progress Strengthens Long-Term ProspectsWhile uncertainty remains, Starknet’s fundamentals have quietly strengthened. Starknet’s CT lead highlighted that Q3 2025 marked the debut of Bitcoin staking on Starknet, enabling BTC holders to earn STRK rewards through a dual-token model. So far, more than 650 BTC (worth $72M) has been staked, pushing TVL to more than triple its previous levels and even stablecoin’s have grown tremendously.

Additional upgrades continue to support this ecosystem expansion. The CT lead’s article further mentions the updates’ importance, like Grinta v0.14.0, which introduced decentralized sequencers offering 0.5-second pre-confirmations and over 2,600 TPS.

Similarly, ZK-STARK proofs, EIP-1559 fee mechanics, and new STRK gas requirements increase efficiency and demand.

Likewise, the LayerZero integrations bridged Starknet to over 150 chains, strengthening its interoperability and DeFi protocols, such as Paradex, which managed to process $170 billion in monthly volume, reinforcing traction.

These advancements, combined with a strong short-term move after Stwo’s release, position STRK crypto for a potentially more meaningful long-term turnaround.

Technical Outlook: What STRK Must Hold for RecoveryThe Starknet price chart shows that despite the rally, major structural barriers persist. For STRK/USD to shift from survival mode to recovery mode, it must close the year above $0.63, a level that represents nearly 250% upside from its current $0.186 price.

If successful, Starknet price forecast models suggest that $0.63 is the near-term target. Meanwhile, effectively flipping this level will hit $1.36 probably by early 2026 upside rally, and also odds suggest for it to reach $2.78, which will mark a full ATH retest if momentum and fundamentals align.

On the contrary, if it fails to reach $0.63 by year-end or does not extend the bullish rally, all eyes will be on its recovery to H1 2026, thereby extending Starknet’s long consolidation phase.

As November progresses, the Starknet price prediction 2025 outlook hinges on whether STRK can convert its latest catalysts into sustained confidence.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

XRP is back in the spotlight after a strong 12% surge in the last 24 hours, now trading around $2.56. The token has outperformed Bitcoin and Ethereum. The rally is driven by short liquidations, rising demand around a potential XRP ETF, and improving overall market sentiment. 

Market expert Ali Martinez said that if the current bull run continues, XRP could see another buying opportunity before a potential rally toward $6, a level not seen in years.

XRP Rally Gains StrengthXRP’s sharp price jump marks a strong comeback from its recent dip to around $2.15 earlier in the week. The global crypto market cap now stands at $3.59 trillion, while Bitcoin has recovered to $106,000.

Although trading volume is still lower than last week, leveraged positions are picking up, which could bring some short-term swings. If buying pressure continues, XRP could aim for the next targets around $2.60 and $2.70, in the next few days.

Market Tailwinds: Economy, ETFs, and RegulationSeveral macroeconomic developments are also acting as catalysts. U.S. President Donald Trump announced a $2,000 stimulus dividend for Americans, which could inject fresh liquidity into markets. At the same time, the U.S. Senate voted 60-40 to advance a bill ending the government shutdown, potentially boosting investor confidence.

On the policy front, Goldman Sachs expects multiple Federal Reserve rate cuts by 2026, which could support risk assets like crypto. Lower interest rates often push more capital into digital assets as investors seek higher returns.

But the biggest catalyst for XRP’s momentum remains the growing talk around XRP exchange-traded funds (ETFs). Multiple XRP ETF filings from Bitwise, Franklin Templeton, and CoinShares — are already listed on the DTCC platform, suggesting launch preparations are underway. 

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

A prominent exchange-traded fund specialist says the first US spot XRP ETFs could debut within days, as Washington moves to end the longest federal shutdown on record and multiple funds surfaced on the Depository Trust & Clearing Corporation’s (DTCC) “active and pre-launch” roster. “Government shutdown ending = spot crypto ETF floodgates opening… In meantime, could see first ‘33 Act spot XRP ETF launch this week,” Nate Geraci wrote on X early Monday, November 10.

The timing hinges on fast-moving developments in Washington. On Monday, November 10, Senate leaders advanced a funding package intended to reopen the government, a step that would bring furloughed Securities and Exchange Commission staff back to work and unfreeze routine registration processing.

Even as the shutdown lingers, infrastructure for prospective spot funds is materializing. DTCC’s official “Exchange Traded Funds – Active and Pre Launch” file—updated November 7—now includes several applicants: Bitwise XRP ETF, Canary XRP ETF, CoinShares XRP ETF, 21Shares XRP ETF, and Franklin XRP ETF. DTCC’s own disclaimer on that page is explicit: the file lists both active ETFs and “pre launch” products that “are not yet active” and cannot be processed “unless and until such securities have received all necessary regulatory and other approvals.”

The convergence of DTCC listings with a prospective government reopening is why Geraci—one of the most closely followed voices in the ETF industry—frames the next several days as a potential inflection point. His post also nods to the legal mechanism that could enable a near-term debut: the Securities Act of 1933’s Section 8(a) pathway to automatic effectiveness.

In recent weeks, several crypto ETF issuers have removed the traditional “delaying amendment” from their S-1 registration statements, which—absent SEC action—allows a filing to go effective automatically after 20 days.

None of the above, however, substitutes for an approval order or the passage of the Section 8(a) waiting period. DTCC listings historically function as plumbing—CUSIP, symbol, and processing readiness—rather than a regulatory blessing.

The presence of leveraged or strategy products tied to the token on the same DTCC sheet and the mix of “Y/N” notations in the “Create/Redeem” column further underscore that DTCC is cataloging what could be processed, subject to regulatory status, rather than declaring anything active. The agency’s own header language leaves no ambiguity on that point.

The policy backdrop matters. Multiple newsrooms reported across the weekend and into Monday that the Senate has taken concrete steps toward reopening the government. If the House follows and the President signs, SEC staff would return, potentially accelerating routine correspondence and any last-mile logistics for issuers that chose not to rely on 8(a) automatic effectiveness.

Until then, issuers that did remove delaying amendments technically do not need an affirmative SEC declaration to become effective after the 20-day clock, but they remain exposed to potential SEC comments or interventions once operations normalize.

At press time, XRP traded at $2.48.

XRP price, 1-day chart | Source: XRPUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter!
For updates and exclusive offers enter your email.

Jake Simmons has been a Bitcoin enthusiast since 2016. Ever since he heard about Bitcoin, he has been studying the topic every day and trying to share his knowledge with others. His goal is to contribute to Bitcoin's financial revolution, which will replace the fiat money system. Besides BTC and crypto, Jake studied Business Informatics at a university. After graduation in 2017, he has been working in the blockchain and crypto sector. You can follow Jake on Twitter at @realJakeSimmons.

The slumbering giant of the altcoin market is starting to stir. Bitcoin is showing signs of preparing for a big move, and therefore the altcoins will probably not be lagging too far behind. $XRP and $ADA are in pole position.

Mother of rallies to come in altcoins

Source: TradingView

Total2 is the chart for the market capitalization of all the altcoins, excluding $BTC. The daily chart above reveals that the altcoins market cap has found strong support at the $1.25 trillion horizontal level. It bounced from there and is now above the major ascending trendline and is currently nestled up against the descending trendline (faint dotted line).

While it’s possible that the altcoins market cap doesn’t break out yet, higher lows have continued to be made since April. When Total2 comes back down again this just might be for the final time before a mother of rallies.

$XRP up 23% in less than a week

Source: TradingView

$XRP has been a high-flyer so far on Monday morning. Up more than 7% on the day, the price is also up nearly 23% since touching the bottom of its channel less than a week ago. 

Judging from the Stochastic RSI indicators in this 12-hour time frame, a local top may be forming soon, if not now. While the high time frame indicators are signalling a very oversold condition, (and that’s what really matters), in the short time frame $XRP is overbought, and we’ll probably have to see perhaps a higher low before the price heads up in all seriousness to the top of the channel and a potential breakout.

$XRP getting ready for high time frame breakout 

Source: TradingView

The 2-week chart says it all for $XRP. After the price erupted out of the triangle back in July and hit a new all-time high of $3.66, the price absolutely needed to enter a new distribution period, and it looks as though that period is coming to an end.

The price has followed a descending channel and probably tested the bottom in the last 2-week period. The Stochastic RSI at the bottom of the chart has the indicator lines perfectly placed for a cross back to the upside. Things are similar in the weekly time frame. This one is probably going to $4 - quite possibly by the end of this year.

$ADA bounces from bottom of descending triangle

Source: TradingView

$ADA looks to have made its own bottom. The price has just bounced from the bottom of a descending triangle and has also punctured through a small descending trendline. It might be expected that the price continues to go back up to the top of the triangle. 

The RSI indicator, at the bottom of the chart, has just broken through its own downtrend line, adding validity to the breakout in the price action.

Explosive breakout coming for $ADA?

Source: TradingView

The weekly time frame for $ADA reveals how the descending triangle is actually part of a much bigger wedge pattern, and that this has been forming for more than 4 years. A breakout from this pattern is likely to be explosive. 

Just like is the case for $XRP, the weekly Stochastic RSI indicators are practically on the floor, while in the 2-week Stochastic RSI the indicators are not far from the bottom. This is setting up for exactly that explosive move.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

The company's paper profit from its BTC investment is more than $20 billion.

Bitcoin (BTC) nosedived severely on a couple of occasions last week, and Strategy (the former MicroStrategy) has used the opportunity to accumulate more assets at lower prices.

Just recently, Michael Saylor (co-founder of the business intelligence software) revealed that the entity has acquired an additional 487 BTC purchased for approximately $102,557 per unit.

The company has achieved BTC Yield of 26.1% YTD 2025 and currently holds 641,692 BTC. It has spent a little more than $47.5 billion to accumulate that impressive stash, with its first buy dating back to August 2020.

Strategy has acquired 487 BTC for ~$49.9 million at ~$102,557 per bitcoin and has achieved BTC Yield of 26.1% YTD 2025. As of 11/9/2025, we hodl 641,692 $BTC acquired for ~$47.54 billion at ~$74,079 per bitcoin. $MSTR $STRC $STRD $STRE $STRF $STRK https://t.co/jTEikuB5RY

— Michael Saylor (@saylor) November 10, 2025

As of this writing, Strategy’s crypto holdings are worth over $68 billion, meaning the firm is sitting on a massive profit of around $20.5 billion (at least on paper).

The latest purchase is more substantial than the ones announced in the previous two weeks. Last Monday, the company disclosed the acquisition of 397 BTC for roughly $45 million, while towards the end of October, it scooped up 390 BTC.

Despite the regular BTC purchases (the company rarely skips a Monday without making such an announcement), Strategy’s shares have been in a massive decline lately. Currently, MSTR trades at around $241, representing a 40% plunge on a six-month scale.

You may also like:

Bitcoin’s Surge Past $106K Liquidates James Wynn 12 Times in 12 Hours

Robert Kiyosaki Sets Huge BTC, ETH Price Targets After Warning of an Impending Crash

Digital Asset Treasury Companies Pour $42.7B Into Crypto in 2025, $22.6B Spent in Q3 Alone

Tags:

About the author

Dimitar got interested in cryptocurrencies back in 2018 amid the prolonged bear market. His biggest passion in the field is Bitcoin and he was fascinated with its journey. With a flair for producing high-quality content, he started covering the cryptocurrency space in late 2018. His hobby is football.

Ethereum News

ETH Volume Soars to New Heights—Speculative Surge Signals Market Energy

TL;DR ETH trading volume remains elevated, driven by derivatives speculation rather than spot demand. Ethereum’s open interest quickly recovered to over $18 billion, growing 5.5%

zkSync News

ZkSync Ignites Investor Optimism with 115% November Surge

TL;DR ZK rose from $0.03 to over $0.07, with spot volumes multiplying by 30. Vitalik Buterin’s public endorsement of ZkSync’s “Atlas” upgrade initiated the rally.

CryptoNews

Aster to Build a Public Blockchain with Zero Fees and a Focus on Privacy

TL;DR Aster will launch a public, zero-fee blockchain focused on privacy, designed for traders seeking lower costs and enhanced confidentiality. The network will feature tokenized

Bitcoin News

ASTER, HYPE Sparked Altcoin Comeback as Bitcoin Rebounded Above $100K

TL;DR: Bitcoin rebounded above $100K after falling below $99K, its lowest in five months. ASTER and HYPE led the altcoin recovery with 6-7% daily gains.

flash news

CZ Stops Sharing Details on Investments and Holdings

Binance founder Changpeng Zhao announced he will cease disclosing personal cryptocurrency purchases. Zhao confirmed this decision on November 5, 2025, through his official X account,

CryptoCurrency News

Anti-CZ Whale Scores Big: $21M Unrealized Profit from $ASTER Short

TL;DR The well known on chain trader “Anti CZ Whale” is sitting on over $21 million in unrealized gains from shorting $ASTER after CZ mentioned

Strategy (MSTR), the largest corporate Bitcoin holder, reported Monday that it purchased $49.9 million worth of BTC last week. The buy brings its total holdings to 641,692 coins, valued at more than $68 billion at current prices, with an average purchase price of $74,079 per Bitcoin.